Nurse's Son Needs Life-Saving Treatment Abroad

Sarah Sloman, a dedicated NHS children's nurse, is appealing for financial assistance to secure life-saving treatment for her three-year-old son, Teddy. Teddy is battling high-risk neuroblastoma, a rare and aggressive childhood cancer. The specific maintenance therapy he needs has unfortunately been withdrawn for NHS patients in the UK by its American manufacturer. This leaves his family in a desperate race against time to raise £250,000 to provide him with the best chance of survival.

Teddy was diagnosed in July of the previous year, and since then, he has endured a grueling nine months of intensive treatment at Noah's Ark Children's Hospital for Wales and in London. This included chemotherapy, major surgery, stem cell harvesting, and proton beam therapy. Despite responding to the initial treatment, Teddy faces a high risk of the cancer returning due to complications during his therapy. His immunotherapy is set to conclude in September, after which he will need to commence the vital maintenance treatment for two years.

The family's preferred option is to procure the drug directly from the manufacturer for administration in the UK under local specialist supervision. If this is not feasible, they may need to seek treatment at specialized centres abroad, with options available in the United States and Rome. Sarah acknowledges the daunting nature of raising the substantial sum but emphasizes its critical importance for Teddy's future.